Get started
Award

R338-2019-2995

Funded outputs count: 5
Funder award ID: R338-2019-2995
OpenAlex ID: G8606761462
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction
2023 · James P Curtain, Carly Adamson, et al. · European Heart Journal · 28
PDF
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
2022 · Pardeep S. Jhund, Toru Kondo, et al. · Nature Medicine · 294
PDF
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
2022 · Jawad H. Butt, Pardeep S. Jhund, et al. · Circulation · 169
PDF
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction
2022 · Jawad H. Butt, Toru Kondo, et al. · Journal of the American College of Cardiology · 47
PDF
Vericiguat, sacubitril/valsartan and more evidence that we are failing our patients
2022 · Jawad H. Butt, John J.V. McMurray · European Journal of Heart Failure · 1
PDF
Year
Topic